Caption Management, LLC Myriad Genetics Inc Call Options Transaction History

Caption Management, LLC

  • $5.74 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$11.25 - $14.75 $562,500 - $737,500
-50,000 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$10.69 - $16.49 $534,500 - $824,499
50,000 New
50,000 $567,000
Q1 2020

May 15, 2020
SELL
$9.78 - $29.53 $195,600 - $590,600
-20,000 Closed
0 $0
Q4 2019

Feb 13, 2020
SELL
$20.93 - $35.1 $558,831 - $937,170
-26,700 Reduced 57.17%
20,000 $544,000
Q3 2019

Nov 14, 2019
BUY
$22.08 - $47.08 $1.03 Million - $2.2 Million
46,700 New
46,700 $1.34 Million

Others Institutions Holding MYGN

# of Institutions
253
Shares Held
90.9M
Call Options Held
100K
Put Options Held
34K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.23B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email